insights_auto
Outlook: 81.2% bullish·0.0% bearish
Go to analysischevron_right
BBIO:NASDAQ
BridgeBio Pharma Inc
$66.50
arrow_downward
-0.69%(-0.46) 1D
$65.99
arrow_downward
-0.77% (-0.51)bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBIO...
Open
$66.78
High
$67.58
Low
$66.15
Mkt. cap
13.00B
Avg. vol.
2.62M
Volume
2.06M
52-wk high
$93.42
52-wk low
$52.75
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
Open
$66.78
High
$67.58
Low
$66.15
Mkt. cap
13.00B
Avg. vol.
2.62M
Volume
2.06M
52-wk high
$93.42
52-wk low
$52.75
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
News stories
From web sources and news partners
Zacks
·
7 hours ago
FDA Grants Priority Review to BridgeBio's Dwarfism Drug Filing
Investing.com
·
11 hours ago
H.C. Wainwright reiterates BridgeBio stock rating on FDA filing
Investing.com
·
11 hours ago
BridgeBio Pharma stock rating reiterated at Buy by Canaccord
Simply Wall Street
·
20 hours ago
Will Priority Review Change BridgeBio Pharma Stock Narrative
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1K
Founded2015
HeadquartersPalo Alto, California, United States
SectorBiotechnology
Websitebridgebio.com